J&J says late-stage COVID-19 vaccine trial fully enrolled - Reuters

Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate. https://www.reuters.com/article/health-coronavirus-vaccines-johnsonjohns-idUSL4N2IY0PL